Background: The human gut microbiome harbors microbes that perform diverse biochemical functions. Previous work suggested that functional variation between gut microbiota is small relative to taxonomic variation. However, these conclusions were largely based on broad pathways and qualitative patterns. Identifying microbial genes with highly variable or invariable abundance across hosts requires a new statistical test.
are either signicantly variable or invariable across samples, without needing to choose a comparison group from either metagenomes or whole genomes. Our method ts gene family abundances to a model and calculates the variance of the residuals, then compares this residual variance statistic to a data-driven null distribution based on the negative binomial distribution. Using simulated data, we show that under certain assumptions, this test has high power (>90%) and controls the false-positive rate appropriately. When these assumptions are violated, we can use simulations to control the false discovery rate (FDR) empirically.
We apply this test to healthy gut metagenomes (n = 123) spanning three dierent shotgun sequencing studies and nd both signicantly invariable (3, 768) and variable (1,219) gene families (FDR<5%). Many pathways, including some commonly viewed as housekeeping or previously identied as stable across gut microbiota (e.g., central carbon metabolism), include signicantly variable gene families. Phylogenetic distribution (PD) correlates overall with variability in gene family abundance, and exceptions to this trend highlight functions that may be involved in adaptation, such as two-component signaling and specialized secretion systems. Proteobacteria emerge as a source for genes with the greatest variability in abundance across hosts, suggesting a relationship between inammation and gene-level dierences in what gut microbiota are doing.
Results

The residual variance statistic captures the variability of gene families across hosts
In metagenomics data, dierent gene families vary widely in average abundance. Gene family abundances can also vary by study, both because of biological dierences between populations, and for technical reasons including library preparation, amplication protocol, and sequencing technology. To account for such eects, we t a linear model of log abundance D g,s for gene g in sample s as a function of a per-gene-family mean G g , osets X g,y for each study y, and residual variation g,s :
D g,s = G g + y∈Y I y,s X g,y + g,s
where I y,s is an indicator variable that is 1 if sample s belongs to study y and 0 otherwise. We take the variance of the residuals, V s ( g,s ), or V g for short, as our statistic. This statistic captures how much variance remains after accounting for dataset-specic and gene-family-
4
. CC-BY 4.0 International license peer-reviewed) is the author/funder. It is made available under a
The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/056614 doi: bioRxiv preprint first posted online Jun. 2, 2016; specic shifts in abundance ( Figure 1 ).
A null distribution based on the negative binomial allows detection of signicant (in)variability
While calculating the residual variance statistic V g allows a ranking of gene families by variability, by itself, it does not tell us whether this variability (or lack thereof ) is surprising.
Since there is no straightforward formula for the p-value associated with this statistic, we developed a method to assess signicance (Supplemental Figure S1 ). We choose the null hypothesis that the metagenomic read count data (before any normalization, e.g., for gene length and average genome size) are distributed negative-binomially. The negative binomial distribution is frequently used to model high-throughput sequencing data [22] , and can be conceptualized as an overdispersed Poisson where the variance can exceed the mean.
To obtain our null distribution, we allow the mean value to change for dierent gene families as observed, but x the overdispersion parameter k that controls the mean-variance relationship across genes. This has similarities to previous approaches to model RNAseq distributions [23] and to identify (in)variable genes from single-cell RNAseq data [24] (see also Discussion). Intuitively, this null hypothesis means that the gene families we identify as signicantly variable or invariable will be those whose abundances are over-or underdispersed, respectively, relative to the median gene family. This choice of null is important:
if we instead simply test for high variance, regardless of mean abundance, highly abundant gene families (e.g., single-copy proteins in the bacterial ribosome) are signicantly variable despite being nearly universally present at equal abundance in each bacterial genome, because genes with high mean abundance will have high variance in any sequencing experiment.
Conversely, thousands of lower-abundance gene families would appear to be signicantly invariable simply by virtue of having relatively low read counts.
Based on simulations with similar properties to real data (see Methods, Supplemental Figure S3 ), we nd that this test has high power (> 0.9). The false positive rate (i.e., type I error α) is well-controlled as long as the overdispersion parameter k used in the null distribution is accurately estimated. This appears to be easiest to achieve when fewer than 50% of gene families are signicantly variable or invariable. To make the test more robust to estimation of k, we developed a simulation based method to empirically identify signicance thresholds that control FDR for both variable and invariable families (Supplemental Table   S7 ).
5
Thousands of gene families in the gut microbiome are signicantly (in)variable
To describe variation within healthy gut microbiota across dierent human populations, we randomly selected 123 metagenomes of healthy individuals from the Human Microbiome Project (HMP) [16] , controls in a study of type II diabetes (T2D) [25] , and controls in a study of glucose control (GC) [26] . These span American, Chinese, and European populations, respectively (see Methods). We map these metagenomes to KEGG Orthology families with ShotMAP [27] and quantify gene family abundance using log-transformed reads per kilobase of genome equivalents (RPKG) [28] . This produces an n × m data matrix D of log-RPKG abundances consisting of n = 17,417 gene families across m = 123 healthy human gut samples.
Before testing for signicantly variable and invariable KEGG families, we conducted a simulation that mirrored this dataset (n = 120, variable-to-invariable gene family ratio between 1:2 and 1:3). The observed α was somewhat higher than the targeted level for the variable gene families (Supplemental Figure S4 ). We therefore used the simulation results to empirically identify FDR controlling signicance thresholds.
We nd 2,357 gene families with more variability than expected and 5,432 with less (leaving 9,628 non-signicant) at an empirical FDR of 5% (Supplemental Figure S5 ). Restricting ourselves further to gene families with at least one annotated representative from a bacterial or archaeal genome in KEGG, we obtain 1,219 signicantly variable and 3,813 signicantly invariable gene families (and 2,194 non-signicant). The dierences in the residual variation of these gene families can be visualized using a heatmap of the residual g,s values (Supplemental Figures S6, S7 ).
Importantly, the magnitude of the residual variance statistic V g is not the sole determinant of signicance, as observed by the overlap in distributions of V g between the variable, invariable, and non-signicant gene families. For example, both low-abundance gene families with many zero values and high-abundance but invariable gene families will tend to have low residual variance, but the evidence for invariability is much stronger for the second group.
Our test accurately discriminates between these scenarios, tending to call the second group signicantly invariable and not the rst (Supplemental Figure S5 , inset).
2.4 Biological pathways, including those in central metabolism, contain a range of stable and variable components
It has been observed that person-to-person dierences in the taxonomic composition of healthy gut microbiomes are much larger than dierences in functional composition [16] .
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Our results support but also qualify this conclusion. Many of the specic pathways identied as stable (e.g., aminoacyl-tRNA metabolism, central carbon metabolism) have more stable than variable genes in our analysis. However, these pathways also include signicantly variable genes (Figure 2 ). For example, even the highly conserved KEGG module set aminoacyl tRNA includes one variable gene at an empirical FDR of 5%, SepRS. SepRS is an O-phosphoseryl-tRNA synthetase, which is an alternative route to biosynthesis of cysteinyltRNA in methanogenic archaea [29] . Methanogen abundance has previously been noted to be variable between individual human guts, though this may be due to variability in DNA extraction for archaea and not due to true dierences in abundance [30] . Another gene in this category is variable at a weaker level of signicance (10% empirical FDR): PoxA, a variant lysyl-tRNA synthetase. Recent experimental work has shown that this protein has a diverged, novel functionality, lysinylating the elongation factor EF-P [31, 32] .
By comparison, in the KEGG module set central carbohydrate metabolism, 77% of the tested prokaryotic gene families were signicantly stable, and 5.6% (5 genes) were signicantly variable (Figure 2 ) at an empirical FDR of 5%. In this case, the variable gene families highlight the complexities of microbial carbon utilization. Glucose can be metabolized by two alternative pathways: the more famous Embden-Meyerhof-Parnas (EMP) pathway (i.e., classical glycolysis), or the Entner-Doudoro pathway (ED). Both take glucose to pyruvate, but with diering yields of ATP and electron carriers; ED also allows growth on sugar acids like gluconate [33] . Indeed, while all genes in the core module of glycolysis dealing with 3-carbon compounds were signicantly invariable across individuals, the ED-specic gene family edd, which takes 6-phosphogluconate to 2-keto-3-deoxy-phosphogluconate (KDPG), was signicantly variable according to our test.
We discovered signicant variability in abundance for other unusual glycolytic enzymes and enzymes in the tricarboxylic acid cycle (TCA). Multifunctional (K16306, K01622) variants of fructose-bisphosphate aldolase were signicantly variable, while the typical FBA enzyme (FbaA) was signicantly stable. A subunit of fumarate reductase, frdD, was also signicantly variable. Fumarate reductase catalyzes the reverse reaction from the typical TCA cycle enzyme succinate dehydrogenase and can be used for redox balance during anaerobic growth [34] . Conversely, the standard succinate dehydrogenase genes sdhA, sdhB and sdhC were signicantly invariable. These results suggest that using our test to identify variable genes within otherwise stable pathways can reveal diverged functionality as well as families that play domain or clade-specic roles.
We also nd that the majority of signicantly variable gene families annotated to bacte-
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. CC-BY 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/056614 doi: bioRxiv preprint first posted online Jun. 2, 2016; rial secretion system (16 out of 18) are involved in specialized secretion systems, especially the type III and type VI systems ( Figure 2D ). These secretion systems are predominantly found in Gram negative bacteria and are often involved in specialized cell-to-cell interactions, between microbes and between pathogens or symbionts and the host. They allow the injection of eector proteins, including virulence factors, directly into target cells [35, 36] . Type VI secretion systems have also been shown to be determinants of antagonistic interactions between bacteria in the gut microbiome [37, 38] . In contrast, gene families in the Sec (general secretion) and Tat (twin-arginine translocation) pathways were nearly all signicantly stable at an empirical FDR of 5%, with only one gene in each being found to be signicantly variable. This contradicts previous suggestions that the Sec and Tat pathways were some of the most variable in the human microbiome [16] . This discrepancy is probably due to our accounting for the mean-variance relationship in shotgun data; the Sec and Tat systems are abundant and phylogenetically diverse [39] .
2.5 Phylogenetic distribution correlates with, but does not totally explain, gene family variability To explore the relationship between gene family taxonomic distribution and variability in abundance across hosts, we constructed trees of the sequences in each KEGG family using ClustalOmega and FastTree. We then calculated phylogenetic distribution (PD), using tree density to correct for the overall rate of evolution [40] (Figure 4a ). Table S1 ). Enriched modules included a two-component system involved in sporulation control (q = 0.018), as well as transporters for rhamnose (q = 0.14), cellobiose (q = 0.14), and alpha-and beta-glucosides (q = 0.14 and q = 0.19, respectively).
These results are consistent with the hypothesis that one function of the gut microbiome is to encode carbohydrate-utilization enzymes the host lacks [41] . Additionally, recent experiments have also shown that the major gut commensal Bacteroides thetaiotaomicron contain enzymes adapted to the degradation of sulfated glycans including GAGs [42, 43] , and that many Bacteroides species can in fact use the GAG chondroitin sulfate as a sole carbon source [44] .
Out of the 298 signicantly-variable gene families with above-median PD, we found no pathway enrichments but three module enrichments.
Only the archaeal (q = 1.5 × 10
. CC-BY 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/056614 doi: bioRxiv preprint first posted online Jun. 2, 2016; and eukaryotic (q = 8.7 × 10 −9 ) ribosomes were enriched, as expected from the abundance patterns of ribosomal proteins from dierent domains of life across hosts (2b). We also discovered an enrichment for the type VI secretion system (q = 0.039).
Finally, gene families described as hypothetical were also enriched in the variable/high-PD gene set (p = 2.4×10 −8 , odds ratio = 2.2) and depleted in the invariable/low-PD set (p = 5.4×10 −13 , odds ratio = 0.41). Intriguingly, specialized secretion systems were also observed to vary within gut-microbiome-associated species in a strain-specic manner, using a wholly separate set of data [45] .
Transporters were also recently observed to show strain-specic variation in copy number across dierent human gut microbiomes [45] , and analyses by Turnbaugh et al. identied membrane transporters as enriched in the variable set of functions in the microbiome [17] .
However, we mainly nd transporters enriched amongst gene families with similar abundance across hosts, despite being phylogenetically restricted (invariable/low-PD genes). Part of this dierence is likely due to our stratifying by phylogenetic distribution, which previous studies did not do.
Proteobacteria are a major source of variable genes
To explore which taxa contribute variable and stable genes, we rst computed correlations between phylum relative abundances (predicted using MetaPhlAn2 [46] ) and gene family abundances. This analysis revealed that Proteobacterial levels are correlated with abundance of many variable genes ( Figure 5b ). Proteobacteria are a comparatively minor component of these metagenomes (median = 1%), compared to Bacteroidetes (median = 59%) and Firmicutes (median = 33%). However, some hosts had up to 41% Proteobacteria. Overgrowth of Proteobacteria has been associated with metabolic syndrome [47] and inammatory bowel disease [48] . Also, Proteobacteria can be selected (over Bacteroidetes and Firmicutes) by intestinal inammation as tested by TLR5-knockout mice [49] , and some Proteobacteria can induce colitis in this background [50] , potentially leading to a feedback loop. Thus, the variable gene families we discovered could be biomarkers for dysbiosis and inammation in otherwise healthy hosts.
We also examined correlations between gene abundance and three taxonomic summary statistics that have been previously linked to microbiome function: average genome size (AGS) [28] , the Bacteroidetes/Firmicutes ratio [17, 51] , and α-diversity (Shannon index). All of these statistics were less often correlated with variable gene families than with invariable or non-signicant gene families (see Supplemental Information, Supplemental Figure S9 ).
These statistics therefore do not explain the variability of gene families in this dataset.
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The variable gene families we identied seem to include both genes whose variance is explained by phylum-level variation (e.g., Proteobacteria), and genes that vary within negrained taxonomic classications, such as strains within species. Also, some gene families may confer adaptive advantages in the gut only within certain taxa. We were therefore motivated to detect lineage-specic variable and invariable gene families, independent of phylum-level trends. To do so, we repeated the test, but using only reads that mapped best to sequences from each of the four most abundant bacterial phyla (Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria). Because we do not necessarily expect the assumption that fewer than 50% of gene families will be signicantly (in)variable to hold within each individual phylum, we estimate the average level of overdispersion from the full dataset instead.
Most (77%) gene families showed phylum-specic eects. Invariable gene families tended to agree, but the reverse was true for variable gene families: 19.4% of gene families that were invariable in one phylum were invariable in all, compared to just 0.34% (8 genes) in the variable set. Gene families invariable in all four phyla were enriched for basal cellular machinery, as expected (Supplemental Table S3 ).
Mirroring results we obtained in Figure 5 , Proteobacteria-specic variable gene families also tended to be variable overall (59%); the opposite trend was true for Bacteroidetes-(12%),
Firmicutes-(29%), and Actinobacteria-specic (18%) variable gene families ( Figure 6A ). This supports the hypothesis that Proteobacterial abundance is a dominant driver of functional variability in the human gut microbiome. It further suggests that many overall-variable gene families are not merely markers for a phylum that varies itself (i.e., Proteobacteria), but are also variable at ner taxonomic levels, such as the species or even the strain level [45, 52] .
Comparing the two dominant phyla in the gut, Bacteroidetes and Firmicutes, we further observe that the overall proportions of variable and invariable families are similar across pathways, with some exceptions: for example, lipopolysaccharide (LPS) biosynthesis has many invariable gene families in Bacteroidetes and very few in Firmicutes, which we expect given that LPS is primarily made by Gram-negative bacteria. Conversely, both two-component signaling and the PTS system have many more invariable gene families in Firmicutes than in Bacteroidetes ( Figure 6B ). However, phylum-specic variable gene families tend not to overlap (median overlap: 0%, compared to 46% for invariable gene families). This is even true for pathways where the overall proportion of variable and invariable gene families is similar, such as cofactor and vitamin biosynthesis and central carbohydrate metabolism ( Figure 6C ).
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The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/056614 doi: bioRxiv preprint first posted online Jun. 2, 2016; Furthermore, the enriched biological functions of the phylum-specic variable gene families dier by phylum (Supplemental Table S4 ). For instance, Proteobacterial-specic variable gene families are enriched (Fisher's test enrichment q = 0.13) for the biosynthesis of siderophore group nonribosomal peptides; iron scavenging is known to be important in the establishment of both pathogens (e.g. Yersinia ) and commensals (E. coli ) [53] . Another phylum-specic variable function appears to be the Type IV secretion system (T4SS) within Firmicutes (q = 0.021): homologs of this specialized secretion system have been shown to be involved in a wide array of biochemical interactions, including the conjugative transfer of plasmids (e.g. antibiotic-resistance cassettes) between bacteria [54] . We conclude that our approach enables the identication of substantial variation within all four major bacterial phyla in the gut, much of which is not apparent when data are analyzed at broader functional resolution or without stratifying by phylum.
Variable genes are not biomarkers for body mass index, sex or age
To explore associations of gene variability with measured host traits, we used a two-sided partial Kendall's τ test that controls for study eects (Methods). Body mass index, sex, and age were measured in all three studies we analyzed. None of these variables correlated signicantly with any variable gene family abundances, even at a 25% false discovery rate.
This suggests that major sources of variation in microbiota gene levels, possibly including diet and inammation, were not measured in these studies.
Discussion
Our test is the rst to provide a statistical basis for determining stable versus variable functions in the human gut microbiome, a ner level of quantication and specicity than previously possible. Prior work examining how gene families and metabolic pathways vary across healthy human gut microbiome samples has tended to focus either on comparisons to other body sites or environments, or on identifying general or qualitative trends in variability.
For example, Segata et al. [55] identied pathways whose abundance diered in the gut versus other body sites. While valuable, this type of analysis answers a distinct question, as it tests the average abundance and not variance, and depends on comparisons between groups. Thus, it would not identify gene families or pathways that these groups might share (e.g., pathways necessary for human symbiosis more broadly). The second type of approach is exemplied by studies from the HMP Consortium [16] and Turnbaugh et al. [17] . Both
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Turnbaugh et al. [17] also compared the variance of gene families in particular pathways across metagenomes to the variance across sequenced whole genomes. They concluded that biological pathways tended to vary less in metagenomes than in whole genomes. However, there are barriers to extending this test to individual gene families or biological pathways.
First, a set of representative whole genomes must be chosen to construct a null distribution.
Choosing an appropriate set of genomes to compare to a metagenome is not trivial, especially since the most appropriate genomes may not have been sequenced. Second, samples from a mixture of genomes should have lower variance than samples from individual genomes in that mixture; accounting for this bias could be dicult as it would depend on the precise composition of the sample. This study did classify gene families into stable versus variable subsets, by looking for families that were observed in all samples versus not observed in at least one. However, while this approach is useful and intuitively appealing, it is more descriptive or qualitative than our method, and would miss gene families that were reliably observed, but whose abundances still varied more than expected between subjects.
We nd that basic microbial cellular machinery, such as the ribosome, tRNA-charging, and primary metabolism, are universal functional components of the microbiome, both in general and when each individual phylum is considered separately. This nding is consistent with previous results [17] , and indeed, is not surprising given the broad conservation of these processes across the tree of life. However, we also identify candidate invariable gene families that have narrower phylogenetic distributions. These include, for example, proteins involved in two-component signaling, starch metabolism, and glycosaminoglycan metabolism. Previous experimental work has underscored the importance of some of these pathways in gut symbionts: for instance, multiple gut-associated Bacteroides species are capable of using the glycosaminoglycan chondroitin sulfate as a sole carbon source [42] , and the metabolism of resistant starch in general is thought to be a critical function of the human microbiome.
These results suggest that the method we present is capable of identifying protein-coding gene families that contribute to tness of symbionts within the gut.
We also identify signicantly variable gene families, including specialized secretion systems, e.g., the T6SS. Phylum-specic tests also reveal that gene families involved in the T6SS
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Though the interpretation of invariable gene families is potentially more straightforward, variable gene families have a variety of ecological interpretations, e.g., rst-mover eects, drift, host demography, and selection within particular gut environments. Computationally distinguishing among these possibilities is likely to present challenges. For example, distinguishing selection from random drift will probably require longitudinal data and appropriate models. Separating eects of host geography, genetics, medical history, and lifestyle will be possible only when richer phenotypic data is available from a more diverse set of human populations. To control for study bias and batch eects, it will be important to include multiple sampling sites within each study.
While statistical tests focused on dierences in variances are not yet common throughout genomics, there is some recent precedent using this type of test to quantify the gene-level heterogeneity in single-cell RNA sequencing data [56, 24] , and to identify variance eects in genetic association data [57] . Like Vallejos et al. [24] , we model gene counts using the negative binomial distribution, and identify both signicantly variable and invariable genes, although we frame our method as a frequentist hypothesis test as opposed to a Bayesian hierarchical model. Unlike previous approaches in this domain, the method we describe does not explicitly decompose biological from technical noise, and therefore does not require the use of experimentally-spiked-in controls, which are not present in most experiments involving sequencing of the gut microbiome.
A similar statistical method for detecting signicant (in)variability such as the one we present here could also be applied to other biomolecules measured in counts, such as metabolites, proteins, or transcripts. Performing such analyses on human microbiota would reveal patterns in the variability in the usage of particular genes, reactions, and pathways, which would expand on our investigation of potential usage based on presence in the DNA of organisms in host stool. Another important extension is to generalize our method for comparing hosts from dierent pre-dened groups (disease states, countries, diets) to identify gene families that are stable in one group (e.g., healthy controls) but variable in another
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Conclusion
This study present a novel statistical method that provides a ner resolution estimate of functional redundancy [58] in the human microbiome than was previously possible. We found that most biological pathways, including tRNA charging, central carbon metabolism, and bacterial secretion, have both invariable and variable components. Some variable genes have surprisingly broad phylogenetic distributions, and Proteobacteria emerge as a major source of variable genes. Since Proteobacteria have also been linked to inammation and metabolic syndrome [47] , we speculate that baseline inammation may be one variable inuencing functions in the gut microbiome.
Methods
Data collection and processing
Stool metagenomes from healthy human guts were obtained from three sources:
1. two American cohorts from the Human Microbiome Project [16] , n = 42 samples selected; 2. a Chinese cohort from a case-control study of type II diabetes (T2D) [25] , n = 44 samples from controls with neither type II diabetes nor impaired glucose tolerance; 3. and a European cohort from a case-control study of glucose control [26] , n = 37 samples from controls with normal glucose tolerance.
After downloading these samples from NCBI's short read archive (SRA), the FASTA-formatted les were mapped to KEGG Orthology (KO) [59] protein families as previously described [27] . For consistency, each sample was rareed to a depth of 1.5×10 7 reads, and additionally, as reads from HMP were particularly variable in length, they were therefore trimmed to a uniform length of 90 bp.
For each sample, we used ShotMAP to detect how many times a particular gene family matched a read (counts; we add one pseudocount for reasons described below). The bitscore cuto for matching a protein family was selected based on the average read length of
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each sample as recommended previously [27] . For every gene family in every sample, we also computed the average family length (AFL), or the average length of the matched genes within a family. Finally, we also computed per-sample average genome size using MicrobeCensus [28] (http://github.com/snayfach/MicrobeCensus). These quantities were used to estimate abundance values in units of RPKG, or reads per kilobase of genome equivalents [28] .
These RPKG abundance values were strictly positive with a long right tail and highly correlated with the variances (Spearman's r = 0.99). This strong mean-variance relationship is likely simply because these abundances are derived from counts that are either Poisson or negative-binomially distributed. We therefore took the natural log of the RPKG values as a variance stabilizing transformation. Because log(0) is innite, we add a pseudocount before normalizing the counts and taking the log transform. Since there is no average family length (AFL) when there are no reads for a given gene family in a given sample, we impute it in those cases using the average AFL across samples.
Model tting
We t a linear model to the data matrix of log-RPKG D of log-RPKG described above, with n gene-families by m samples, to capture gene-specic and dataset-specic eects:
where g ∈ [1, n] is a particular gene family, s ∈ [1, m] is a particular sample, G g is the grande or overall mean of log-RPKG s Dg,s m for a given gene family g, Y is the set of studies, I y,s is an indicator variable valued 1 if sample s is in study y and 0 otherwise, X g,y is a mean oset for gene family g in study y, and the residual for a given gene family and sample are given by g,s . For each gene family, the variance across samples of these g,s , which we term the residual variance or V g , becomes our statistic of interest.
Overall trends in these data are explained well by this model, with an R 2 = 0.20. The residuals, which are approximately symmetrically distributed around 0, represent variation in gene abundance not due to study eects.
Modeling residual variances under the null distribution
Having calculated this statistic V g for each gene family g, we then need to compare this statistic to its distribution under a null hypothesis H 0 . This requires us to model what the data would look like if in fact there were no surprisingly variable or invariable gene families.
To do this, we use the negative binomial distribution to model the original count data (before 15
adding pseudocounts and normalization to obtain RPKG).
The negative binomial distribution is commonly used to model count data from high throughput sequencing. It can be conceptualized as a mixture of Poisson distributions with dierent means, which themselves follow a Gamma distribution. Like the Poisson distribution, the negative binomial distribution has an intrinsic mean-variance relationship. However, instead of a single mean-variance parameter as in the Poisson, the negative binomial can be described with two, a mean parameter and a size parameter, which we refer to here as k such that k = µ 2 σ 2 −µ . k ranges from (0, ∞), with smaller values corresponding to more overdispersion (i.e., higher variance given the mean) and larger values approaching, in the limit, the Poisson distribution.
To model the case where no gene family has unusual variance given its mean value, i.e., our null hypothesis, we assume that the data are negative-binomially distributed with the observed means µ g,y for each gene g and study y, but where the amount of overdispersion is modeled with a single size parameter k y for each study y:
To estimate this k y , the overall size parameter for a given study y, we estimate the mode of per-gene-family size parameters k g,y within data set y, using the method-of-moments estimator for each k g,y . We accomplish this by tting a Gaussian kernel density estimate to the log-transformed k g,y values, and then nding the k y value that gives the highest density.
(From simulations, we found that the mode method-of-moments was more robust than the median or harmonic mean: see Supplemental Figure S2 .) We can then easily generate count data under this null distribution, add a pseudocount and normalize by AFL and AGS, t the above linear model, and obtain null residual variances V 0 g using exactly the same procedure described above.
Statistical signicance is then obtained by a two-tailed test:
Here, B refers to the number of null test statistics V 0 g (in this case, B = 750), and the overlined test statistics refer to their mean across the null distribution.
The resulting p-values are then corrected for multiple testing by converting to FDR q-values using the procedure of Storey et al. [60] as implemented in the qvalue package in R [61] . An alternative approach to determining signicance is based on the bootstrap.
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A similar non-parametric bootstrap approach has previously been successfully applied to testing for dierences in gene expression [63] .
As expected, when the residuals are plotted in a heatmap as in Figure S6 , variable gene families are generally brighter (i.e., more deviation from the mean) than invariable gene families, though not exclusively: this is because our null distribution, unlike the visualization, models the expected mean-variance relationship. 
Power analysis
The test we present controls α as expected if the correct size parameter k is estimated from the data (Supplemental Figure S2a-b) . Estimating this parameter accurately is known to be dicult, however, particularly for highly over-dispersed data [64] , and in this case we must also estimate this parameter from a mixture of true positives and nulls. We nd that the mode of per-gene-family method-of-moments estimates is more robust to dierences in the ratio of variable to invariable true positives (Supplemental Figure S2e-g ) than the median or harmonic mean (the harmonic mean mirrors the approach in Yu et al. [23] ).
Power analysis was performed on simulated datasets comprising three simulated studies.
For each study, 1,000 gene families were simulated over n ∈ {60, 120, 480, 960} samples.
Null data were drawn from a negative-binomial distribution with a randomly-selected size parameter k in common to all gene families, which was drawn from a log-normal distribution (log-mean= −0.65, sd= 0.57). Gene family means were also drawn from a log-normal (log mean= 2.94, sd = 2.23). True positives were drawn from a similar negative-binomial distribution, but where the size parameter was multiplied by an eect size z (for variable
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. CC-BY 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/056614 doi: bioRxiv preprint first posted online Jun. 2, 2016; gene families) or its reciprocal 1/z (for invariable gene families). The above test was then applied to the simulated data, and the percent of Type I and II errors was calculated by comparing to the known gene family labels from the simulation. Using similar parameters to those estimated from our real data, we see that α decreases and power approaches 1 with increasing sample size (see Supplemental Figure S3 ) and that n = 120 appears to be sucient to achieve control over α.
However, at n = 120, we also noted that α appeared to be greater for variable vs.
invariable gene families (Supplemental Figure S4) , possibly because accurately detecting additional overdispersion in already-overdispersed data may be intrinsically dicult. We therefore performed additional simulations to determine q-value cutos corresponding to an empirical FDR of 5%. We calculated appropriate cutos based on datasets with 43% true positives and a variable:invariable gene family ratio ranging from 0.1 to 10, taking the median cuto value across these ratios (Supplementary Table S7 ). Using these cutos, the overall dataset had 45% true positives and a variable:invariable gene family ratio of 0.43.
Calculating phylogenetic distribution of gene families
The phylogenetic distribution (PD) of KEGG Orthology (KO) families was estimated using tree density [40] . We rst obtained sequences of each full-length protein annotated to a particular KO, and then performed a multiple alignment of each family using ClustalOmega [65] . These multiple alignments were used to generate trees via FastTree [66] . For both the alignment and tree-building, we used default parameters for homologous proteins.
For all families represented in at least 5 dierent archaea and/or bacteria (6,703 families total), we then computed tree densities, or the sum of edge lengths divided by the mean tip height. Using tree density instead of tree height as a measure of PD corrects for the rate of evolution, which can otherwise cause very highly-conserved but slow-evolving families like the ribosome to appear to have a low PD [40] . Empirically, this measure is very similar to the number of protein sequences (Supplemental Figure S8 ), but is not as sensitive to high or variable rates of within-species duplication: for example, families such as transposons, which exhibit high rates of duplication as well as copy-number variation between species, have a larger number of sequences than even very well-conserved proteins such as RNA polymerase, but have similar or even lower tree densities, indicating that they are not truly more broadly conserved.
Many protein families (8,931 families) did not have enough observations in order to
reliably calculate tree density, with almost all of these being annotated in only a single bacterium/archaeum. For these, we predicted their PD by extrapolation. To predict PD,
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we used a linear model that predicted tree density based on the total number of annotations (including annotations in eukaryotes). In ve-fold cross-validation, this model actually had a relatively small mean absolute percentage error (MAPE) of 13.1%. We also considered a model that took into account the taxonomic level (e.g., phylum) of the last common ancestor of all organisms in which a given protein family was annotated, but this model performed essentially identically (MAPE of 13.0%). Predicted tree densities are given in Supplemental   Table S6 . The PD of gene families varied from 1.2 (an iron-chelate-transporting ATPase only annotated in H. pylori ) to 434.9 (the rpoE family of RNA polymerase sigma factors).
Gene family enrichment
We were interested in whether particular pathways were enriched in several of the gene family sets identied in this work. For subsets of genes (such as those with specically low PD), a 2-tailed Fisher's exact test (i.e., hypergeometric test) was used instead to look for cases in which the overlap between a given gene set and a KEGG module or pathway was signicantly larger or smaller than expected. The background set was taken to be the intersection of the set of gene families observed in the data with the set of gene families that had pathway-or module-level annotations. p-values were converted to q-values as above. Finally, enrichments were enumerated by selecting all modules or pathways below q ≤ 0.25 that had positive odds-ratios (i.e., enriched instead of depleted).
Associations with clinical and taxonomic variables
We were interested in using a non-parametric approach to detect association of residual RPKG with clinical and taxonomic variables (e.g., the inferred abundance of a particular phylum via MetaPhlan2). To take into account potential study eects in clinical and taxonomic variables without using a parametric modeling framework, we used partial Kendall's τ correlation as implemented in the ppcor package for R [67] , coding the study eects as binary nuisance variables. Kendall's τ was used over Spearman's ρ because of better handling of ties (an issue with taxonomic variables especially, since many, particularly at the ner-grained levels, were often zero). The null distribution was obtained by permuting the clinical/taxonomic variables within each study 250 times, and then re-assessing the partial τ . Finally, p-values were calculated by taking the fraction of null partial correlations equally or more extreme (i.e., distant from zero) than the real partial correlations.
Phylum-level relative abundances were predicted from the shotgun data using MetaPhlAn2 with the --very-sensitive ag [46] .
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Phylum-specic tests
We created taxonomically-restricted data sets in which the abundance of each gene family was computed using only metagenomic reads aligning best to sequences from each of the four most abundant bacterial phyla (Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria). Phylum-specic data were obtained from the overall data as follows. First, the NCBI taxonomy was parsed to obtain species annotated below each of the four major bacterial phyla (Bacteroidetes, Firmicutes, Actinobacteria, and Proteobacteria); these species were then matched with KEGG species identiers. Next, the original RAPSearch2 [68] results were ltered, so that the only reads remaining were those for which their best hit in the KEGG database originally came from the genome of a species belonging to the specic phylum in question (e.g., E. coli for Proteobacteria). Finally, when performing the test, normalization for average genome size was accomplished by normalizing gene family counts by the median abundance of a set of 29 bacterial single-copy gene families [69] , which had been ltered in the same phylum-specic way as all other gene families; this approach is similar to the MUSiCC method for average genome size correction [70] . This also controls for overall changes in phylum abundance. Finally, k y values for individual studies were estimated based on the non-phylum-restricted data, since the expectation that < 50% of gene families were dierentially variable might not hold for each individual phylum. We used the same q-value cutos as in the overall test to set an estimated empirical FDR (Supplementary Table S7 ).
Otherwise, tests were performed as above.
Codebase
The scripts used to conduct the test and related analyses are available at the following URL:
http://www.bitbucket.org/pbradz/variance-analyze Counts of reads mapped to KEGG Orthology (KO) groups and average family lengths for all of the samples used in this study can be obtained at FigShare:
• https://figshare.com/s/fcf1abf369155588ae41 (overall) • https://figshare.com/s/90d44cffdfb1d214ef83 (phylum-specic) 6 Author contributions PHB performed the experiments and analyses. PHB and KSP developed the test, designed the experiments, wrote the paper, and read and approved the nal manuscript.
20
. S A , S B , etc.) . These reads will eventually map to multiple gene families G. MicrobeCensus [28] is used to estimate average genome size, while Shotmap [27] is used to map reads, yielding both matrices of counts (right hand side) and matrices of average lengths of the best-hit proteins (average family length or AFL). AFL and AGS estimates are used to normalize counts. B) We calculate our statistic and assign p-values as follows. First, we normalize counts from Shotmap using AFL and AGS, log-transform the resulting reads per kilobase of genome (RPKG), then apply a simple linear model to t dataset-and gene-family-specic eects. The resulting residuals (residual log RPKG) form a matrix of G genes by S A +S B +S C samples. We take the variance across all samples for each gene to obtain a 1xG vector of residual variances. To get a null distribution, we can either use data generated from a negative binomial t, or, optionally, from a negative binomial t integrated with (shaded section) bootstrap resampling. For the negative binomial t, from the count matrices, we estimate the mean of each gene in each dataset, as well as datasetspecic overdispersion parameters k. We then use these to make simulated count datasets ( × B indicating that this card is replicated once for each of B simulations), which we process as in the case of the real data, yielding simulated log-RPKG matrices and simulated residual variances for each gene family. For the resampling (if applicable), we sample with replacement from each count dataset, yielding resampled counts. We process these in the same way to obtain resampled residual variances. Finally, if using the resampled data, we center and scale the resampled residual variances using per-gene-family means and standard deviations from the simulated residual variances; otherwise, we simply take the values from applying the test to the negative binomial simulations. These form the background distribution (bottom panel, solid curve) for each gene in G ( × G indicating that this card is replicated once for each of G genes). The actual observed residual variance (dashed line) is then compared to this distribution to obtain p-values (gray shaded area).
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. CC-BY 4.0 International license peer-reviewed) is the author/funder. It is made available under a The copyright holder for this preprint (which was not . http://dx.doi.org/10.1101/056614 doi: bioRxiv preprint first posted online Jun. 2, 2016; Figure S8 : Number of leaves is correlated with tree density, but tree density corrects for the overall rate of evolution. The number of leaves (i.e., individual sequences) is plotted vs. tree density on a log-log scatter plot, with each circle representing one gene family. Two outliers with lower density than expected are plotted in colors: a putative transposase (green) and a Staphylococcus leukotoxin (red). Both families have large numbers of sequences from the same organism. 
